newsfilter
← Latest News
GlobeNewswire·

KemPharm to Report Third Quarter 2022 Financial Results

CELEBRATION, Fla., Nov. 01, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH) (KemPharm, or the Company), a biotechnology company focused on the discovery, development and commercialization of novel treatments for